Core Viewpoint - Barclays has downgraded Keurig Dr Pepper's stock rating from "Overweight" to "Hold" and reduced the target price by 33% to $26, citing increased uncertainty and disruption from the planned separation of its beverage and coffee businesses [1][2] Group 1: Business Separation - Keurig Dr Pepper plans to split its beverage and coffee businesses into two independent entities after acquiring JDE Peet's, with the coffee segment projected to generate approximately $16 billion in annual net sales [1] - The beverage segment, which includes brands like Dr Pepper and Canada Dry, is expected to exceed $11 billion in annual net sales [1] - The separation is seen as a rational move, but the complexities involved in the transition may lead to higher uncertainty in the next 12 months [1] Group 2: Analyst Insights - Analyst Lauren Lieberman noted that the fundamental situation of Keurig Dr Pepper no longer shows a clear relative advantage as it did previously [2] - The beverage business is likely to face structural adjustments post-separation due to shared market channels and production models [2] - The coffee business is expected to gain scale and product diversity through integration, but significant challenges remain, especially considering JDE Peet's inconsistent performance since its IPO in 2020 [2] Group 3: Stock Performance - Following the announcement of the JDE Peet's acquisition, Keurig Dr Pepper's stock has declined by 17% and is currently trading at a five-and-a-half-year low [2] - The new target price reflects a 2% downside potential from the current stock price, indicating that uncertainties related to the announced transaction are largely priced in [2]
巴克莱:Keurig Dr Pepper(KDP.US)分拆业务正确但执行复杂 下调评级至“持股观望”